Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126874111 | 12687411 | 1 | I | 20160713 | 20160824 | 20160826 | 20160826 | EXP | FR-ROCHE-1820477 | ROCHE | 77.00 | YR | M | Y | 0.00000 | 20160826 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126874111 | 12687411 | 1 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | Y | 0 | ||||||||||
| 126874111 | 12687411 | 2 | PS | Rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | FIRST CYCLE OF CHEMOTHERAPY | Y | 103705 | 338 | MG | SOLUTION FOR INFUSION | /cycle | |||||
| 126874111 | 12687411 | 3 | SS | Rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | SECOND CYCLE OF CHEMOTHERAPY | Y | 103705 | 900 | MG | SOLUTION FOR INFUSION | /cycle | |||||
| 126874111 | 12687411 | 4 | SS | BENDAMUSTINE HYDROCHLORIDE. | BENDAMUSTINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | FIRST CYCLE OF CHEMOTHERAPY | Y | 0 | 126 | MG | /cycle | ||||||
| 126874111 | 12687411 | 5 | SS | BENDAMUSTINE HYDROCHLORIDE. | BENDAMUSTINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | SECOND CYCLE OF CHEMOTHERAPY | Y | 0 | 160 | MG | /cycle | ||||||
| 126874111 | 12687411 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 126874111 | 12687411 | 7 | C | PREVISCAN (FRANCE) | FLUINDIONE | 1 | Unknown | 0 | 20 | MG | TABLET | ||||||||
| 126874111 | 12687411 | 8 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | ||||||||||||
| 126874111 | 12687411 | 9 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 126874111 | 12687411 | 10 | C | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126874111 | 12687411 | 1 | Product used for unknown indication |
| 126874111 | 12687411 | 2 | Chronic lymphocytic leukaemia |
| 126874111 | 12687411 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126874111 | 12687411 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126874111 | 12687411 | Dermatitis exfoliative | |
| 126874111 | 12687411 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126874111 | 12687411 | 1 | 20160713 | 20160713 | 0 | |
| 126874111 | 12687411 | 2 | 20160616 | 0 | ||
| 126874111 | 12687411 | 3 | 20160712 | 20160718 | 0 | |
| 126874111 | 12687411 | 4 | 20160616 | 0 | ||
| 126874111 | 12687411 | 5 | 20160712 | 20160713 | 0 |